Fritzenschaf H, Kohlpoth M, Rusche B, Schiffmann D
Academy for Animal Protection, Neubiberg, Germany.
Mutat Res. 1993 Sep;319(1):47-53. doi: 10.1016/0165-1218(93)90029-d.
Seventy-five chemicals, carcinogens and noncarcinogens, were tested in the SHE (Syrian hamster embryo) micronucleus test in vitro. Substances inducing a reproducible and dose dependent increase in micronucleus frequency were regarded as positive. The acquired data were analyzed for correlations with results obtained from the in vivo mouse bone marrow micronucleus test and from morphological transformation of SHE cells. Out of 48 carcinogens tested 41 (85%) yielded a positive result and out of 17 noncarcinogens all proved negative. For 7 chemicals no carcinogenicity data were available so far; these compounds yielded no response in the mouse bone marrow and in the SHE micronucleus assay. For 3 chemicals only inadequate carcinogenicity data were available. A high degree of concordance with data from the in vivo micronucleus test was found (89%) and the accordance with results from morphological SHE cell transformation was even higher (95%). These findings provide new evidence that the in vitro SHE micronucleus test does in fact represent a short-term test of high predictive value.
在体外叙利亚仓鼠胚胎(SHE)微核试验中对75种化学物质(包括致癌物和非致癌物)进行了测试。诱导微核频率出现可重复且剂量依赖性增加的物质被视为阳性。对获得的数据进行了分析,以研究其与体内小鼠骨髓微核试验结果以及SHE细胞形态转化结果之间的相关性。在测试的48种致癌物中,41种(85%)产生了阳性结果,而17种非致癌物均被证明为阴性。目前有7种化学物质尚无致癌性数据;这些化合物在小鼠骨髓和SHE微核试验中均无反应。有3种化学物质仅有不充分的致癌性数据。发现与体内微核试验数据有高度一致性(89%),与SHE细胞形态转化结果的一致性甚至更高(95%)。这些发现提供了新的证据,表明体外SHE微核试验实际上是一种具有高预测价值的短期试验。